Study Stopped
Could not get funding
The Effect of Atrial Fibrillation Hemodynamics on Regulation of Cerebral Blood Flow
1 other identifier
interventional
N/A
1 country
1
Brief Summary
The proposed research will investigate whether the irregular effects of atrial fibrillation on the body's circulation directly impacts the regulation of cerebral blood flow. To further delineate this finding, investigation of these potential effects will include differences in postural positioning. This data will be used to further understand the overall hemodynamic effects of atrial fibrillation on extra-cardiac organs of the body.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Oct 2007
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2007
CompletedFirst Submitted
Initial submission to the registry
August 29, 2008
CompletedFirst Posted
Study publicly available on registry
September 3, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2009
CompletedJanuary 9, 2019
January 1, 2019
2 years
August 29, 2008
January 7, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
to determine whether the irregular effects of atrial fibrillation on the body's circulation directly impacts the regulation of cerebral blood flow
0
Study Arms (1)
1
EXPERIMENTALPatients referred for elective direct current cardioversion (DCCV) of atrial fibrillation.
Interventions
non-invasive tests including Transcranial Doppler ultrasound (TCD), manual cuff blood pressure (BP), beat to beat BP monitoring by a Portapress monitor, and respiratory tidal CO2
Eligibility Criteria
You may qualify if:
- Subjects with atrial fibrillation scheduled for DCCV
- Subjects must be at least 18 years of age
- Subjects must have the ability to understand and sign informed consent and be willing to comply with full testing and evaluation
You may not qualify if:
- Subjects in sinus rhythm without assessment of any prior atrial fibrillation by this research team
- Subjects unable to understand and given informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UT Southwestern Medical Center
Dallas, Texas, 75390, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jose A Joglar
University of Texas Southwestern Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 29, 2008
First Posted
September 3, 2008
Study Start
October 1, 2007
Primary Completion
October 1, 2009
Study Completion
October 1, 2009
Last Updated
January 9, 2019
Record last verified: 2019-01